Enzymatic production of glycosylated synthons

US10696995B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696995-B2
Application numberUS-201615559193-A
CountryUS
Kind codeB2
Filing dateMar 17, 2016
Priority dateMar 19, 2015
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for producing a glycosylated synthon or a monomer. Said method includes at least one step of placing at least one glycan-saccharase in the presence of at least one hydroxylated synthon and at least one saccharose. The invention also relates to a method for producing a glyco(co)polymer, including polymerizing at least two monomers separately obtained from the enzymatic glycosylation method according to the invention, and to a method for producing a glyco(co)polymer, preferably a block glyco(co)polymer, including coupling at least two monomers separately obtained from the enzymatic glycosylation method according to the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for manufacturing a glycosylated synthon, or monomer, comprising at least one step of placing at least one glycan-saccharase in contact with at least one hydroxylated synthon and at least one sucrose, in which: (A) said hydroxylated synthon is chosen from the group constituted of: (i) (meth)acrylate/(meth)acrylamide synthons of formula (I): in which: R 1 represents a hydrogen atom or a C 1 -C 3 alkyl; R 2 represents a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; and X 1 represents —(O)—, —(NH)—, —(S)— or —(NR′ 2 (OH))—, with R′ 2 representing a C 1 -C 20 alkylene group; or a group —(C 2 H 4 O) m —, with m being an integer between 1 and 10; (ii) styrene-based synthons of formula (II): in which R 3 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; (iii) N-carboxyanhydride (NCA) synthons of formula (III): in which R 4 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; (iv) lactone/lactam/thiolactone synthons of formula (IV): in which: R 5 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) m , with m being an integer between 1 and 10; n represents an integer between 1 and 20; X 2 represents —(O)—, —(NH)— or —(S)—; and R 6 represents a hydrogen or a C 1 -C 20 alkyl group; (v) synthons of formula (V): in which R 7 represents a C 1 -C 20 alkylene group; and (vi) synthons of formula (VI): in which R 8 represents a C 1 -C 20 alkylene group; and (B) said glycan-saccharase is selected from the group consisting of a sequence having at least 80% identity with SEQ ID NO: 1, a sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446; a sequence having at least 80% identity with SEQ ID NO: 11; a sequence having at least 80% identity with SEQ ID NO: 12; a sequence having at least 80% identity with SEQ ID NO: 13; a sequence having at least 80% identity with SEQ ID NO: 14; a sequence having at least 80% identity with SEQ ID NO: 15; a sequence having at least 80% identity with SEQ ID NO: 16; a sequence having at least 80% identity with SEQ ID NO: 17; and a sequence having at least 80% identity with SEQ ID NO: 18. 2. The process as claimed in claim 1 , in which the sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446 is chosen from: a sequence having at least 80% identity with SEQ ID NO: 2, said sequence having an amino acid X 1 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 3, said sequence having an amino acid X 2 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 4, said sequence having an amino acid X 3 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 5, said sequence having an amino acid X 4 representing an amino acid chosen from the group constituted of C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 6, said sequence having an amino acid X 5 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 7, said sequence having an amino acid X 6 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 8, said sequence having an amino acid X 7 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, 5, T, W and Y; a sequence having at least 80% identity with SEQ ID NO: 9, said sequence having an amino acid X 8 representing an amino acid chosen from the group constituted of A, C, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; and a sequence having at least 80% identity with SEQ ID NO: 10, said sequence having an amino acid X 9 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, W and Y. 3. The process as claimed in claim 1 , in which the sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446 is chosen from: a sequence having at least 80% identity with SEQ ID NO: 2, said sequence having an amino acid X 1 representing an amino acid chosen from the group constituted of C, H, K, M, N, Q, S, T and V; a sequence having at least 80% identity with SEQ ID NO: 3, said sequence having an amino acid X 2 representing an amino acid chosen from the group constituted of H, L, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 4, said sequence having an amino acid X 3 representing an amino acid chosen from the group constituted of C, D, E, G, H, I, K, M, N, P, Q, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 5, said sequence having an amino acid X 4 representing an amino acid chosen from the group constituted of C, D, E, F, M, N, P, Q, S, T, V and W; a sequence having at least 80% identity with the sequence SEQ ID NO: 6, said sequence having an amino acid X 5 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, P, Q, S, T, V and W; a sequence having at least 80% identity with the sequence SEQ ID NO: 7, said sequence having an amino acid X 6 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, K, L, M, N, Q, S, V and Y; a sequence having at least 80% identity with SEQ ID NO: 8, said sequence having an amino acid X 7 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, N, Q, R, S, T, W and Y; a sequence having at least 80% identity with SEQ ID NO: 9, said sequence having an amino acid X 8 representing an amino acid chosen from the group constituted of A, E, F, G, H, I, K and L; a sequence having at least 80% identity with SEQ ID NO: 10, said sequence having an amino acid X 9 representing an amino acid chosen from the group constituted of A, C, G, K, L, M, N, and S. 4. The process as claimed in claim 1 , in which the hydroxylated synthon is chosen from the group consisting of 2-(hydroxy)ethyl methacrylate (HEMA), N-(hydroxy)methylacrylamide (NHAM), N-(hydroxy)ethylacrylamide (HEAA), 4-vinylphenol (VP), 4-vinylbenzyl alcohol (VBA), 4-(hydroxy)methyloxazolidine-2,5-dione (HMNCA), a-(hydroxy)methylcapr

Assignees

Inventors

Classifications

  • having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin · CPC title

  • Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title

  • acting on glycosyl compounds (3.2) · CPC title

  • containing no aromatic rings in the alcohol moiety · CPC title

  • containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-acryloylmorpholine} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696995B2 cover?
The present invention relates to a method for producing a glycosylated synthon or a monomer. Said method includes at least one step of placing at least one glycan-saccharase in the presence of at least one hydroxylated synthon and at least one saccharose. The invention also relates to a method for producing a glyco(co)polymer, including polymerizing at least two monomers separately obtained fro…
Who is the assignee on this patent?
Inst Nat De La Rech Agronomique Inra, Institut Nat Des Sciences Appliquees De Toulouse Insat, Centre Nat Rech Scient, and 4 more
What technology area does this patent fall under?
Primary CPC classification C12P19/60. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).